Pfizer Dostinex (cabergoline)

Dostinex is a prescription medication containing the active ingredient cabergoline, primarily used to treat disorders related to high levels of the hormone prolactin. The brand was originally developed by Farmitalia-Carlo Erba, an Italian pharmaceutical company, before it was acquired by Pharmacia & Upjohn, which subsequently merged with Pfizer.

Today, the brand is owned and distributed by Pfizer Inc., one of the world's largest biomedical and pharmaceutical companies. While Pfizer is headquartered in the United States, the manufacturing of Dostinex tablets for global markets, including those for the Russian-language labeling shown in the image, typically occurs at Pfizer's specialized manufacturing facilities in Ascoli Piceno, Italy.